Last reviewed · How we verify

NCT04251000

Infrared Photomodulation Therapy for Seasonal Affective Disorder

Completed NA Last updated 11 February 2021
What this trial tests

NA trial testing Joovv Mini in Seasonal Affective Disorder in 60 participants. Completed in 1 July 2020.

Timeline
27 February 2020
Primary endpoint
31 May 2020
1 July 2020

Quick facts

Lead sponsorProofPilot
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment60
Start date27 February 2020
Primary completion31 May 2020
Estimated completion1 July 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

ProofPilot

Who can join

Adults 18 to 100, any sex, with Seasonal Affective Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

During winter months in northern latitudes use of Joovv device on self-reported non-clinical mental health (aka mood), sleep and energy levels. Participants will also submit Withings and Oura activity and sleep data.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Joovv Mini

Trials testing the same drug.

Other ProofPilot trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04251000.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing